Stellas, D., El Hamidieh, A., & Patsavoudi, E. (2010). Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BioMed Central.
Stile di citazione ChicagoStellas, Dimitris, Avraam El Hamidieh, e Evangelia Patsavoudi. Monoclonal Antibody 4C5 Prevents Activation of MMP2 and MMP9 By Disrupting Their Interaction With Extracellular HSP90 and Inhibits Formation of Metastatic Breast Cancer Cell Deposits. BioMed Central, 2010.
Citazione MLAStellas, Dimitris, Avraam El Hamidieh, e Evangelia Patsavoudi. Monoclonal Antibody 4C5 Prevents Activation of MMP2 and MMP9 By Disrupting Their Interaction With Extracellular HSP90 and Inhibits Formation of Metastatic Breast Cancer Cell Deposits. BioMed Central, 2010.